Filename: BNSSG-ICB-PHARMACEUTICAL-POLICY-APRIL-2024-V0.16-FINAL.PDF
File type: PDF
File size: 653 KB
Description: The purpose of this policy is to provide a framework for the ICBs in their interaction with pharmaceutical companies and other device and appliance manufacturers of prescribable products..
This policy provides a framework to assist ICB staff in determining when commercial sponsorship or a joint working agreement with the pharmaceutical industry is appropriate.
It sets out the principles and standards which should be applied when the employees of the ICB or their representatives engage with the pharmaceutical industry.
It is strongly recommended that member practices adopt this policy. It is essential that all projects or dealings with the Pharmaceutical Industry are open and transparent.
For further information, please contact the Medicines Optimisation team: bnssg.medicines-optimisation@nhs.net
Policy updated April 2024.